PharmGKB summary: Zidovudine pathway

Yogita Ghodke; Peter L. Anderson; Katrin Sangkuhl; Jatinder Lamba; Russ B. Altman; Teri E. Klein

Journal Article

PharmGKB summary: Zidovudine pathway

Ghodke Y
Anderson P
Sangkuhl K
et al.

Pharmacogenetics and Genomics (2012) 22(12) 891-894

DOI: 10.1097/FPC.0b013e32835879a8

17Citations

55Readers

Get full text

Cite

CITATION STYLE

APA

Ghodke, Y., Anderson, P. L., Sangkuhl, K., Lamba, J., Altman, R. B., & Klein, T. E. (2012). PharmGKB summary: Zidovudine pathway. Pharmacogenetics and Genomics, 22(12), 891–894. https://doi.org/10.1097/FPC.0b013e32835879a8

Readers' Seniority

PhD / Post grad / Masters / Doc 15

63%

Researcher 6

25%

Professor / Associate Prof. 2

Lecturer / Post doc 1

Readers' Discipline

Medicine and Dentistry 9

33%

Biochemistry, Genetics and Molecular Bi... 8

30%

Agricultural and Biological Sciences 7

26%

Pharmacology, Toxicology and Pharmaceut... 3

11%

Article Metrics

Mentions

News Mentions: 1

References: 1

Social Media

Shares, Likes & Comments: 14

View details >

PharmGKB summary: Zidovudine pathway

Author supplied keywords

References Powered by Scopus

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Mitochondrial myopathy caused by long-term zidovudine therapy

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients

Cited by Powered by Scopus

Antiviral effects of plant-derived essential oils and their components: An updated review

Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders

Antiviral drug delivery system for enhanced bioactivity, better metabolism and pharmacokinetic characteristics

Register to see more suggestions

Cite

Readers' Seniority

Readers' Discipline

Article Metrics